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Summary 
Cell surface glycoproteins were isolated 
from the lysates of ‘251-labeled normal human 
mammary epithelial cells (NHMEC) and from 
the human breast carcinoma cell line MCF-7, 
of blood-group 0 phenotype, by affinity chro- 
matography on Griffonia simplicifolia I lectin- 
Sepharose. Specific elution of glycoproteins 
from the column with methyl cr-D-galactoside 
suggests the presence of a-D-galactosyl groups 
on these moieties. SDS-PAGE analysis of 
isolated glycoproteins revealed both quan- 
titative and qualitative differences between 
glycoproteins from normal and malignant cells. 
Three major glycoproteins of M, 180 kDa, 85 
kDa and the 44 kDa were obtained from 
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MCF-7 cells. The 180-kDa glycoprotein was 
absent in NHMEC and the 44-kDa glycopro- 
tein was very weakly expressed in these cells. 
The only glycoprotein which was found in 
almost equal amount in the lysate from both 
normal and malignant cells was the 85-kDa 
glycoprotein. These results indicate differences 
between normal human mammary epithelial 
cells and one kind of malignant human mam- 
mary epithelial cells, in ;he expression of 
glycoproteins containing a-D-ga/actosy/ 
groups, irrespective of blood-group 
phenotype; they also demonstrate that U-D- 
galactosyl group are expressed in a very 
restrictive manner on the surface of this tumor 
cell line. 
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Introduction 
The expression of specific oligosaccharide 
structures on tumor cells may contribute to 
their tumorigenicity or metastatic behavior [ 11. 
Varani et al. [Z] have shown that the expres- 
sion of a-D-galactosyl residues on the cell sur- 
face is strongly correlated with metastatic 
potential of murine fibrosarcoma cells. Highly 
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metastatic cells from a number of different 
tumors expressed high levels of a-D-galactosyl 
groups whereas low malignant cells from the 
same tumors did not. Moreover, results with 
the same cells indicated that these o-D- 
galactosyl groups were located on glycopro- 
teins which may play a role in tumor cell at- 
tachment to collagen [3]. Castronovo et al. [4] 
reported the presence of cr-D-galactosyl 
groups on another highly malignant murine 
cell line, M04. Their results also suggested that 
these groups may play a role in the formation 
of metastases, inasmuch as they were able to 
reduce lung colonization using anti-o-D- 
galactosyl antibodies. While previous studies 
have documented a strong, positive relation- 
ship between cell surface expression of o-D- 
galactosyl groups and malignant potential 
among murine tumor cell lines, much less 
work has been done in humans. Recently 
Castronovo et al. [5] also demonstrated the 
presence of a-D-galactosyl groups on certain 
human tumor cell lines derived from human 
brain, breast and chorion as well as on some 
human breast cancer cells obtained at biopsy. 
These carbohydrate groups on choriocar- 
cinema cells (BEWO) were implicated in the 
process of attachment of these cells to laminin 
and to the vascular wall. While these previous 
studies support the notion that, in human as in 
mouse, the expression of cY-D-galactosyl 
groups is associated with the malignant 
phenotype, additional studies are necessary to 
determine the significance of such a rela- 
tionship. 
An important question to be addressed con- 
cerns the nature of the tumor cell surface 
molecules which bear the a-D-galactosyl 
groups. Terminal cr-D-galaCtOSyl groups are 
expressed on murine laminin from EHS sar- 
coma [6] and studies by McCoy et al. [7] in- 
dicated that laminin was responsible for at least 
some of the residues on murine fibrosarcoma 
cells. However, laminin probably accounts for 
only a minor portion of the cr-D-galactosyl 
groups on murine cells. Grimstad and Bosnes 
[8] indicated that o-D-galaCtOSyl groups which 
contribute to tumor cell attachment are located 
on molecules other than laminin. However, 
these molecules have not been identified. Fur- 
ther, laminin from human cells does not con- 
tain terminal cr-D-galactosyl groups [q] . 
In order to address these questions, we have 
developed a procedure for the isolation of 
glycoproteins bearing cr-D-galactosyl groups 
from the human cells. Our previous studies 
with glycoproteins containing o-D-galactosyl 
groups on the surface of macrophages showed 
that the expression of these carbohydrates is 
limited to two major glycoproteins (Petryniak 
et al., unpublished data). Utilizing this pro- 
cedure, we have compared the expression of 
glycoproteins bearing a-D-galactosyl groups, 
on normal human breast epithelial cells and 
malignant MCF-7 human breast carcinoma 
cells. We found that there are few glycopro- 
teins with cr-D-galactosyl groups on the surface 
of each kind of cell. Furthermore, there are 
substantial differences in the electrophoretic 
mobility profiles of the glycoproteins isolated 
from the normal and malignant cells. 
Materials and Methods 
Cells 
Normal human mammary epithelial cells 
(NHMEC) and breast carcinoma cells. 
NHMEC were obtained from reduction mam- 
moplasty of an individual with blood-group B 
phenotype and established in monolayer 
culture as described by Soule and McGrath 
[lo]. Briefly, fresh tissue was dissected into 
small pieces with the aid of a scalpel and then 
dissociated in collagenase and hyaluronidase. 
Fibroblasts were removed by differential adhe- 
sion. The dissociated cells were then plated on 
plastic using a mixture of Dulbecco’s modified 
minimal essential medium and Ham’s F12 me- 
dium. The medium was prepared de novo 
without inclusion of CaClz in the balanced salt 
solution. The medium was supplemented with 
100 units/ml penicillin, 100 pg/ml strep- 
tomycin, cholera enterotoxin (100 ng/ml) , 
epidermal growth factor (20 ng/ml), horse 
serum (5%), insulin (10 pg/ml) and cortisol 
(1.4 x 10 -6 M) . Finally, CaClz was added to 
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bring the final concentration to 2 mM for 
plating and cells were maintained in identical 
media with 16 PM CaClz after attachment. 
MCF-7 human breast carcinoma cells were 
obtained from the American Type Culture Col- 
lection. This cell culture was established from 
an individual of blood group 0 phenotype. 
They were maintained in monolayer culture 
using minimal essential medium of Eagle with 
Earle’s salts, non-essential amino acids, 100 
units/ml of penicillin, 100 pg/ml of strep- 
tomycin and 10% fetal bovine serum as 
culture medium. The cells were grown at 37OC 
and 5% CO2 and subcultured by trypsiniza- 
tion as required. 
Reagents 
14C-Labeled molecular weight marker- 
proteins were obtained from BRL Inc. 
(Bethesda, MD). These included: myosin, 200 
kDa; phosphorylase B, 97.4 kDa; bovine 
serum albumin, 68 kDa and ovalbumin, 43 
kDa. Iodogen was from Pierce Rockford, IL. 
Griffonia simplicifolia I lectin was purified from 
seeds provided by Calbiochem as previously 
described [ll]. The lectin was coupled to 
Sepharose 4B by the CNBr procedure [12]. 
The conjugate contained approximately 1.1 
mg of lectin per ml of settled beads. 
Cell surface labeling 
Both NHMEC and MCF-7 cells were 
surface-labeled with lZ510dine using the 
iodogen technique [13]. Briefly: to approx- 
imately 5 x lo6 cells suspended in 2 ml of 
PBS in a glass vial coated with 800 pg of 
iodogen, 1.5 mCi of lz5NaI (carrier free) was 
added. The suspension was mixed for 15 min 
at room temperature and cells were transferred 
to polypropylene tubes and washed four times 
with 15 ml of PBS, sedimenting for 5 min at 
400 x g each time. 
Isolation of glycoproteins 
All purification steps were carried out at 
4O C, unless stated otherwise. ‘251-Labeled 
cells were lysed and subjected to affinity chro- 
matography. Lysis was carried out on an ice 
water-bath for 3 min (pH 8.2) in 0.01 M 
Tris - HCI buffer containing 0.15 M NaCl, 1% 
BSA and 4% Triton X-100. Freshly prepared 
protease inhibitors, were added to this lysing 
buffer just prior to lysis. Inhibitors included 
aprotinin (10 pg), antipain (50 pg), ben- 
zamidine HCI (100 pg), chymostatin (100 pg), 
iodoacetamide (1 mM) leupeptin (10 pg), 
pepstatin (100 pg) , 1, lo-phenanthroline (5 
mM) and PMSF (2 mM). (Numbers in paren- 
theses represent final concentrations of in- 
hibitor per ml of buffer). The lysate was 
centrifuged for 15 min in a microfuge at 15 
100 x g. The supernatant from the lysate was 
applied immediately to the Griffonia 
simplicifolia I lectin-Sepharose column (0.7 x 
8 cm). The column was equilibrated with 
PBS/Ca2+ and washed successively with buf- 
fers (see Fig. 1) until the cpm dropped below 
1000 per fraction. Absorbed material was 
specifically eluted with methyl cY-D-galactoside 
and analyzed by SDS-PAGE. 
Acrylamide gel electrophoresis was carried 
out according to Laemmli [14] in 1.5 mm thick 
7.5% acrylamide slab gels in the presence of 
0.1% SDS, at constant current of 25 mA. For 
autoradiography, gels were dried and exposed 
to Kodak X-Omat XAR 5 films for 7 - 14 days. 
M, of glycoproteins was determined from the 
standard curve fitted by linear regression. 
Results and Discussion 
In order to show that the structural dif- 
ference between NHMEC and mammary car- 
cinoma cells in the expression of the a-D-Gal 
epitope is irrelevant to blood-group 
phenotype, MCF-7 carcinoma cells from a 
blood group 0 individual were chosen. These 
individuals do not express the Q-D-Gal 
epitopes inasmuch as they lack CY-D- 
galactosyltransferase. In contrast, individuals 
with blood group B phenotype do contain w 
D-Gal residues linked to fucosylated oligosac- 
charides. Therefore NHMEC were from a 
blood group B individual to minimize the pos- 
sible differences between these two kinds of 
cells regarding the expression of the a-D-Gal 
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epitope. Affinity chromatography of lysates 
from ‘251-labeled NHMEC and from malignant 
MCF-7 cells on the Griffonia simplicifolia I 
lectin-Sepharose column resulted in peaks 
eluted specifically with methyl a-D-galactoside 
(Fig. 1, Panel A and B) . Incorporation of 1251 
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Fig. 1. Affinity chromatography on Griffonia 
simplicifolia I lectin-Sepharose of lysates from ceils label- 
ed with lz51. Lysates from NHMEC (panel A) and 
MCF-7 cells (panel B) were applied to a column (0.7 x 
8.0 cm) equilibrated in PBS/Ca ‘+ and was washed suc- 
cessively with 50 ml of PBS/Ca” containing 1% Triton 
X-100 and 50 ml of PBS/Ca’+ without Triton X-100. 
The column was equilibrated with PBS/Ca’+ containing 
0.2% octyl glucoside (buffer A). Fraction of 1.3 ml were 
collected. The flow rate was 16 ml/h. Absorbed material 
was eluted with 15 ml of 100 mM methyl a-D- 
galactoside in buffer A. 
that the eluted material is probably a glycopro- 
tein in nature and that it contains terminal a-D- 
galactosyl groups. There was more 1251- 
labeled material eluted from the lysate of 
MCF-7 cells than NHMEC. However, an 
answer to the question as to whether this dif- 
ference results from a different number of 
receptors on each kind of cell would require 
quantitative studies. Materials in both peaks 
eluted from Griffonia simplicifolia I lectin- 
Sepharose column were analyzed by SDS- 
PAGE (Fig. 2). Autoradiograms of the material 
resolved in the gel revealed both qualitative 
and quantitative difference between glycopro- 









Fls. 2. Autoradiogram of SDS-PAGE of *Z51-labeIed 
glycoproteins from NHMEC and MCF-7 cells. Glycopro- 
teins were isolated by affinity chromatography on Grij- 
fonio simplicifolia I lectin-Sepharose and eluted with 
methyl cy-D-galactoside. Electrophoresis was carried out 
in a 7.5% acrylamide gel at constant current of 25 mA. 
(a) molecular weight markers; (b) NHMEC; (c) MCF-7 
cells (unreduced conditions); (d) MCF-7 cells (reduced 
with 2% DTT). 
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glycoproteins are expressed specifically or at 
higher levels in the MCF-7 cells. 
Three major glycoproteins of M, 180 kDa, 
85 kDa and 44 kDa were found in the lysate 
from MCF-7 cells (Fig. 2~). These glycopro- 
teins appear to be cell membrane components 
inasmuch as they were labeled on the surface 
of intact cells with 1251 by the insoluble 
iodogen reagent which can not enter the cell. 
Of these three glycoproteins in the tumor cell 
lysate, the glycoprotein of 180 kDa represents 
the strongest band; it was completely absent in 
the lysate from normal cells (Fig. Zb). This 
glycoprotein was also insensitive to reduction 
with fi-mercaptoethanol (Fig. 2d) suggesting 
the lack of subunit structure linked by disulfide 
bonds. It will be of interest to determine if this 
glycoerotein is breast cancer-specific or 
whether it is may be present in other types of 
cancer cells. The 44-kDa glycoprotein, which 
also gave a strong band in the lysate from 
MCF-7 cells, was barely detectable in the lysate 
from NHMEC (Fig. 2b) . The 44-kDa glycopro- 
tein from MCF-7 cells migrated as a sharp 
band whereas that from normal cells moved as 
a broader, diffuse band (Fig. 2b, c). Whether 
these glycoproteins from the two types of cells 
are the same remains to be determined? The 
only glycoprotein which appeared to be pres- 
ent in approximately equal amounts in the 
lysate from both kinds of cells was the 85-kDa 
component. Again, whether they are identical 
cannot be answered at this point. 
These results suggest that during the process 
of malignant transformation of MCF-7 cells, 
glycoproteins containing cr-D-galactosyl groups 
are altered and/or expressed and suggest that 
the o-D-Gal epitope on the MCF-7 carcinoma 
cells is different from the blood-group-B struc- 
ture. Determination of the linkage between the 
o-D-Gal groups and the subterminal carbohy- 
drate would be of obvious interest. Im- 
munochemical studies suggest that this linkage 
might be al - 3, but such an epitope has not 
been found in humans [15]. Its appearance in 
MCF-7 breast cancer cells might be of general 
biological significance and the glycoproteins 
described here might provide a tool for such 
structural studies. In addition to this major 
component, lysates from normal cells showed 
additional, very weak bands of 40 kDa, 50 
kDa and a diffuse zone in the range of 
133- 167 kDa. These were absent from 
lysates of the MCF-7 cells (Fig. 2~). Both the 
85-kDa and 44-kDa glycoproteins from 
MCF-7 cells showed a decrease in their mobili- 
ty after reduction with fi-mercaptoethanol and 
their apparent M, increased to 100 kDa and 
48 kDa, respectively. This suggests that they 
may consist of single polypeptide chains with 
intramolecular disulfide bonds. The 180-kDa, 
85-kDa and 44-kDa glycoproteins we isolated 
from MCF-7 cells are clearly different from 
laminin. This is in agreement with the observa- 
tion of Grimstad and Bosnes who stated the (Y- 
D-galactopyranosy] end-groups occur on spe- 
cies of cell-surface molecules other than 
laminin [8]. 
Are the glycoproteins isolated from MCF-7 
cells identical to those previously described? 
Carcinoembryonic antigen (CEA) is also in the 
range of M, 180 kDa [16] and has been found 
on breast carcinoma cells [ 171. However CEA 
as reported by Lisowska et al. [18] has a 
subunit structure and, moreover, does not 
contain cr-D-galactosyl groups [19]. In only 
very few cases have specific glycoproteins 
been shown to be associated with breast carci- 
noma cells [20 - 251. These include a 180 kDa 
glycoprotein defined by monoclonal antibodies 
as described by Ring et al. [25]; however, 
there are differences between the 180 kDa 
glycoprotein described here, and the one 
described previously with the same molecular 
weight. The apparent M, of the glycoprotein 
described by Ring et al. increased to 200 kDa 
after reduction with fl-mercaptoethanol where- 
as the glycoprotein we isolated was insensitive 
to reduction. Moreover, these investigators did 
not detect this glycoprotein on MCF-7 cells. A 
membrane glycoprotein associated with 
human breast cancer tissue described by Ed- 
wards et al. [21] has a M, of 43 kDa. Whether 
this glycoprotein is identical to the glycoprotein 
of M, 44 kDa we isolated, remains to be deter- 
mined. All other glycoproteins described 
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previously [19,21-231 have differed in _ - 
molecular weight from the glycoproteins 
described here. 
Currently, the biological role(s) of breast 
cancer-associated glycoproteins remains un- 
known. However, involvement of molecules 
containing a-D-galactosyl groups in the forma- 
tion of metastases has been indicated. a-D- 
Galactosyl groups are more strongly expressed 
on murine tumor cells than on those from 
humans [26,27]. Nevertheless, their presence 
on tumor cells from both species pose the 
question as to whether there may be an evolu- 
tionary relationship between these glycopro- 
teins, and whether they might play a role in 
human tumor metastasis. Identification of 
molecules containing this carbohydrate group 
on tumor cell surfaces, as well as their full bio- 
chemical and immunochemical characteriza- 
tion, may provide an approach to address 
these questions. 
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